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 Background 
 Acute exacerbations of chronic obstructive pulmo-
nary disease (COPD) are a frequent cause of emergency 
department visits and hospitalizations. In the United 
States there was an average of 0.6 million emergency de-
partment visits per year for acute exacerbations from 
1993 to 2005  [1] resulting in more than 500,000 hospital-
izations per year  [2] . 
 An exacerbation of COPD is defined by the Global Ini-
tiative for Chronic Obstructive Lung Disease (GOLD) as 
a change in the patient’s ‘baseline dyspnea, cough, and/or 
sputum that is beyond day-to-day variations, is acute in 
onset, and may warrant a change in regular medication’ 
 [3] . The management in emergency departments of pa-
tients experiencing an acute exacerbation varies despite 
guideline-recommended care  [1] . There is even more un-
certainty regarding the management of COPD patients in 
primary care  [4, 5] . Several risk factors for relapse after 
acute exacerbations have been identified. These include 
the number of previous exacerbations, the use of home 
oxygen, low lung function, FEV 1  ! 35%, the absence of a 
primary caregiver and the choice of oral therapy  [6–16] . 
The question remains: how should a patient with COPD 
be managed after hospitalization or emergency depart-
ment visit for an acute exacerbation? 
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 Abstract 
 The objective of this review is to sum up the literature re-
garding the management of patients with chronic obstruc-
tive pulmonary disease (COPD) after hospitalization for an 
acute exacerbation. Guidelines recommend a follow-up 4–6 
weeks after hospitalization to assess coping strategies, in-
haler technique, the need for long-term oxygen therapy and 
the measurement of FEV 1 . This review discusses the follow-
up of patients with exacerbations of COPD, the use and value 
of spirometry in their further management, the potential 
benefit of home monitoring, the value of long-term oxygen 
therapy, the value of self-management programs including 
the use of action plans, the potential benefit of noninvasive 
ventilation as well as the value of early rehabilitation. There 
is not enough literature to allow specific recommendations 
and to define components of a care plan after hospitaliza-
tion for an acute exacerbation; however, early rehabilitation 
should be included.  Copyright © 2009 S. Karger AG, Basel 
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 The objective of this study was to review the literature 
regarding the follow-up of patients with exacerbations, 
the use and value of spirometry in their further manage-
ment, the potential benefit of home monitoring, the value 
of long-term oxygen therapy, the value of self-manage-
ment programs including the use of action plans, the po-
tential benefit of noninvasive ventilation as well as the 
value of early rehabilitation.
 Follow-Up  
 The COPD guidelines published by GOLD recom-
mend a follow-up visit 4–6 weeks after hospitalization for 
COPD including an assessment of the patient’s ability to 
cope in his usual environment, a reassessment of inhaler 
technique, measurement of FEV 1 and an assessment of 
the need for long-term oxygen therapy  [3] .
 Up to one third of the patients presenting at the emer-
gency department with an acute exacerbation are newly 
diagnosed with COPD  [17] . After an emergency depart-
ment visit for an exacerbation of COPD there is a 21–28% 
relapse rate during the first 2 weeks after discharge  [13, 
18] . In the study conducted by Murata et al.  [13] the re-
lapse rate leveled off within the first 14 days after dis-
charge. Patients with asthma were also included in this 
study while patients with an exacerbation requiring hos-
pitalization were excluded  [13] . In the prospective multi-
center study by Kim et al.  [18] only patients with acute 
exacerbations of COPD were included. Patients requiring 
hospitalization were also excluded. Patients who showed 
a high risk of relapse needing urgent attention had a his-
tory of prior emergency care utilization  [18] . Patients who 
frequently use emergency care services more often lack a 
primary caregiver than those who use emergency servic-
es less frequently  [15] . On the other hand, in a different 
study, COPD patients with intensified access to primary 
care showed a trend toward higher readmission rates 
than the control group, although the study was not pow-
ered for subgroup analysis according to disease categories 
 [19] . 
 In other studies, relapse was defined as an event oc-
curring within a maximum period of 4 weeks  [7, 9, 20, 
21] . 
 It has also been shown that exacerbations are not ran-
dom events but that the risk of recurrence is greatest 
within the 8 weeks following the initial event  [22] . If, as 
recommended by the GOLD guidelines, a patient is seen 
for follow-up 4–6 weeks after an exacerbation, the pri-
mary caregiver misses out on more than 20% of the re-
lapses which occur within this time period ( fig. 1 ). The 
question remains whether a follow-up earlier after dis-
charge could reduce the high relapse (or re-exacerbation) 
rate. 
 In the study by Casas et al.  [23] patients were recruited 
after hospitalization for an acute exacerbation of COPD 
and either assigned to standard care or to an integrated 
care intervention. Patients in the integrated care group 
were thoroughly assessed at discharge in terms of their 
respiratory disease, comorbidities and their social sup-
port. These patients were also educated on self-manage-
ment and they had access to a specialized nurse via call 
center. No regular follow-up was scheduled. The afore-
mentioned measures reduced the rehospitalization rate 
for the period of 1 year but had no influence on mortal-
ity  [23] . 
 Hermiz et al.  [24] conducted a study, randomizing pa-
tients after hospitalization for an acute exacerbation to a 
control group receiving standard care and an interven-
tion group. Patients in the intervention group were vis-
ited by a nurse within 1 week after discharge, were edu-
cated on disease management and received a care plan. 
This intervention did not reduce the number of emer-
gency department visits or hospital admissions  [24] .
 Table 1 sums up the characteristics of the mentioned 
studies.
 To the best of our knowledge there is no study compar-
ing the relapse rate of COPD patients after hospitaliza-
tion for an acute exacerbation with differences in timing 
or frequency of follow-up visits as the sole intervention. 
0 42
Time (weeks)
COPD
exacerbation
Recommended
follow-up
21–28%
relapse rate
 Fig. 1. Recommended follow-up in relation to relapse rate. 
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 Spirometry  
 The GOLD guidelines recommend spirometry with 
measurement of FEV 1 4–6 weeks after hospitalization for 
an acute exacerbation of COPD  [3] .
 In patients with moderate to severe COPD a low level 
of lung function has been shown to be an independent 
risk factor for exacerbation and hospitalization. In the 
study by Niewoehner et al.  [25] the percentage of predict-
ed FEV 1 was predictive of exacerbations and hospitaliza-
tion within a 6-month period  [25] . However, the use of 
spirometry for monitoring disease or modifying therapy 
according to spirometric results has not yet been evalu-
ated in randomized controlled trials  [26] . 
 The spirometry results obtained 4–6 weeks after an 
acute exacerbation might help to identify patients who 
are at higher risk of relapse or rehospitalization, but there 
are no data regarding the benefit of therapeutic interven-
tions based upon these results.
 Self-Management and the Use of Action Plans  
 A variety of studies have evaluated the benefits of pa-
tient education and the use of action plans in the manage-
ment of patients with COPD. The study designs vary 
greatly regarding the choice of intervention and follow-
up times. 
 For their study Bourbeau et al.  [27] recruited patients 
who had been hospitalized for an acute exacerbation dur-
ing the previous year. Patients were only included if the 
time period between exacerbation and inclusion was at 
least 4 weeks. The interventions included patient educa-
tion, an individualized action plan and exercise. The hos-
pital admission rate for exacerbations and the emergency 
department visits were significantly reduced in the inter-
vention group within the 12-month follow-up period 
 [27] . In the study by Coultas et al.  [28] patients received 
education in the form of problem-based learning and an 
individually tailored action plan. These measures did not 
result in fewer hospitalizations or emergency department 
Table 1. Overview of studies regarding relapse after COPD exacerbation
Study Characteristics of
patients included
Number of patients/ED 
visits or hospitalizations
Length of
follow-up
Relapse rate Definition of relapse
Murata
et al. [14]
Patients visiting ED for
exacerbation
496/868 ED visits 14 days 28.1% Unscheduled visit to ED for 
respiratory symptoms
Kim
et al. [18]
Patients visiting ED for
exacerbation
151/151 ED visits 14 days 21% Unscheduled visit to physician for 
worsening of COPD symptoms
Tsai
et al. [15]
Patients visiting ED for
worsening of COPD symptoms
388/1,009 ED visits 1 year 21% in 14 days Unscheduled visit to ED for 
worsening of COPD symptoms
Weinberger
et al. [19]
Patients hospitalized with
congestive heart failure,
diabetes mellitus, COPD
583 with COPD/
583 hospitalizations
6 months Not powered for 
subgroup of COPD 
patients
Readmission
Adams
et al. [7]
ED visits for COPD
exacerbation
172/362 ED visits 14 days 22% Return visit to ED with persistent 
or worsening symptoms
Dewan
et al. [9]
Outpatients with COPD
exacerbation
228/232 exacerbations 4 weeks (failure to
respond)/24 months
14.7% failure-
to-respond rate
Persistence or worsening of COPD 
symptoms
Aaron
et al. [20]
Patients visiting ED for COPD
exacerbation
147/147 exacerbations 30 days 27% Unscheduled visit to physician’s 
office or ED because of worsening 
COPD symptoms
Niewoehner
et al. [21]
Patients hospitalized for COPD
exacerbation
271 6 months 30-day treatment
failure rate of 27%
Treatment failure (readmission, 
death, intubation)
Casas
et al. [23]
Patients hospitalized for COPD
exacerbation
155/155 hospitalizations 12 months 31 vs. 49%
readmission rate
Readmission
Hermiz
et al. [24]
Patients hospitalized for COPD
exacerbation
177/177 hospitalizations 3 months 24 vs. 18%
hospitalization
Frequency of patients’ 
presentation and admission to 
hospital
ED = Emergency department.
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visits within a 6-month follow-up period  [28] . No change 
in the hospitalization rate within 1 year of follow-up was 
seen in stable COPD patients selected by general practi-
tioners who were assigned to a care plan  [29] . In contrast 
to the first-mentioned study by Bourbeau et al.  [27] , the 
studies by Coultas et al.  [28] and Martin et al.  [29] did not 
include any form of exercise in the intervention groups. 
However, a study by Monninkhof et al.  [30] , for which 
patients from an outpatient pulmonary clinic were re-
cruited and randomized to a self-management interven-
tion group that included education and a fitness program 
or to a control group, failed to show a positive effect on 
the number of exacerbations in the intervention group. 
The number of hospitalizations or emergency depart-
ment visits was not reported. In the study by Rea et al. 
 [31],  stable COPD patients were recruited and the inter-
vention group was assigned a care plan, action plan, reg-
ular check-ups and pulmonary rehabilitation. These pa-
tients showed a lower hospital admission rate compared 
to their pretrial rate. However, when compared to the 
control group, the hospital admission rate did not de-
crease significantly  [31] . 
 Owing to the great heterogeneity of interventions and 
different follow-up periods, it is difficult to make spe-
cific recommendations. Self-management interventions 
for patients with COPD that focus on educating them on 
the disease and the skills needed to guide their health be-
havior might be associated with a reduction in hospital 
admissions, but there is insufficient information to spec-
ify detailed measures  [32] . Data on self-management in-
terventions directly following hospitalizations for an 
acute exacerbation of COPD, not including rehabilitative 
programs, are lacking.
 The review of action plans in the management of 
COPD in the Cochrane Database includes 3 studies and 
concludes that the use of action plans shows no effect on 
health care utilization but does have a positive effect on 
the self-initiation of antibiotics and/or oral steroids  [33] . 
The studies included in the Cochrane review are based 
on stable COPD patients recruited either from outpatient 
clinics or from general practitioner surgeries  [33–35] . 
There is no literature regarding the use of action plans 
directly following hospitalization for an exacerbation of 
COPD and its potential benefit in reducing readmission 
or relapse, especially its effect on the high acute relapse 
rates. 
 Use of Home Monitoring  
 Few studies have evaluated the benefits of home mon-
itoring in patients with COPD and its effect on relapse 
rates, quality of life and health care costs. Vitacca et al. 
 [36] conducted a telemedicine study in patients needing 
mechanical ventilation or long-term oxygen therapy. Pa-
tients randomized to the intervention group received a 
pulse oximetry device and had scheduled telemonitoring 
appointments as the main measures. In patients with 
COPD a reduction in the hospitalization rate was shown 
within a 1-year follow-up period  [36] . In the study by Ca-
sas et al.  [23] patients discharged after an acute exacerba-
tion were randomized to usual care or an intervention 
group that included self-management strategies, a care 
plan and scheduled telemedicine contacts with a special-
ized nurse. Patients in the intervention group were less 
likely to be hospitalized within a 1-year follow-up period 
 [23] . There is no information available regarding patients 
being discharged after an acute exacerbation and the val-
ue of different forms of home monitoring, e.g. symptom 
diary, pulse oximetry measurements or frequent peak 
flow measurements. 
 Long-Term Oxygen Therapy 
 Clinical guidelines recommend an assessment of the 
need for long-time oxygen therapy 4–6 weeks after an 
exacerbation  [3] , as studies have shown a survival benefit 
for severely hypoxemic patients with COPD  [37, 38] and 
a reduction in the number of hospitalizations  [39] . If a 
patient is medically unstable at the time of oxygen thera-
py initiation, a reevaluation is recommended 1–3 months 
later  [40] . As most patients start their domiciliary oxygen 
therapy immediately after hospitalization  [39] , the rec-
ommended reevaluation could be included in the afore-
mentioned follow-up 4–6 weeks after an exacerbation, 
provided that medical stability has been achieved. Oba et 
al.  [41] concluded in their cross-sectional study that most 
patients were prescribed long-term oxygen therapy when 
clinically unstable, and that a significant proportion of 
these patients remained on this therapy without a reas-
sessment. Close to 60% of patients who were adequately 
reevaluated were taken off the oxygen therapy  [41] . Nor-
moxemic emphysema patients and COPD patients with 
only moderate hypoxemia do not benefit from long-term 
oxygen therapy  [42, 43] . Guyatt et al.  [44] conducted a 
randomized trial of strategies for assessing the eligibility 
for long-term oxygen therapy, in order to restrict this 
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therapy to those who benefit. A reassessment of the pa-
tients after 2 months of clinical stability resulted in a sig-
nificant reduction of patients eligible for oxygen therapy 
and therefore in a reduction of costs without raising mor-
tality  [44] . To assess patients 4–6 weeks after an exacerba-
tion for their need for long-time oxygen therapy might be 
too early as clinical stability has not been reached. The 
value of continuous oxygen therapy commenced imme-
diately after exacerbation and its effect on the early re-
lapse rate has not been studied.
 Noninvasive Ventilation 
 Patients benefit from positive-pressure ventilation for 
acute respiratory failure secondary to an exacerbation of 
COPD  [45] . In chronic COPD patients, noninvasive ven-
tilation might result in a reduction of hospitalizations but 
has not been shown to reduce mortality  [46, 47] . Patients 
with a recent exacerbation that were offered domiciliary 
noninvasive ventilation benefited by attaining a reduc-
tion in readmissions  [48] ; however, controlled random-
ized studies are missing  [49] . The results of the studies 
mentioned are summarized in  table 2 . The value of sub-
sequent domiciliary noninvasive ventilation in patients 
that have recently been hospitalized for an exacerbation 
and have received noninvasive ventilation during hospi-
talization has to be elucidated.
 Early Rehabilitation  
 Rehabilitation that started within a few days of hospi-
tal admission for an acute exacerbation has been shown 
to cause an increase in exercise capacity  [50–52] . The hos-
pital readmission rate decreased when respiratory reha-
bilitation was started while the patient was still in hospi-
tal for an acute exacerbation, or immediately after dis-
charge, if a supervised exercise program was continued 
for 6 weeks to 6 months  [53–55] . A meta-analysis of ran-
domized controlled trials showed that patients benefit 
from respiratory rehabilitation after an acute exacerba-
tion of COPD by attaining an improvement in their qual-
ity of life and their exercise capacity. A reduction in hos-
pital readmissions and mortality has also been shown 
 [56] .
 Conclusions 
 The COPD guidelines published by GOLD recom-
mend a follow-up visit 4–6 weeks after hospitalization for 
an acute exacerbation to assess the patients’ coping abil-
ity, FEV 1 , inhaler technique, understanding of treatment 
and their need for long-term oxygen therapy  [3] . There is 
a paucity of literature regarding the follow-up of patients 
after hospitalization for an acute exacerbation of COPD. 
Several interventions have been studied to reduce the 
high relapse rate in these patients. In their systematic re-
view of the chronic care model in COPD management, 
Adams et al.  [57] conclude that patients who received at 
least 2 chronic-care-model components had lower hospi-
talization rates, but they also ‘highlight the need for well-
designed trials’  [57] . Rehabilitation is recommended after 
an acute exacerbation because it has been shown to re-
duce the rehospitalization rate and improves exercise ca-
pacity and quality of life  [56] . However, the availability of 
rehabilitation poses a problem for many patients in dif-
ferent health care systems. 
Table 2. Noninvasive ventilation in COPD patients
Study Characteristics of patients included Number
of patients
Intervention Follow-
up
Outcome
Tuggey
et al. [48]
Patients with recent exacerbation who
tolerated NIV and responded well to it
13 Provision of domiciliary NIV
service
1 year Reduction in readmissions and hospital 
costs
Clini
et al. [47]
Patients with stable COPD,
hypercapnic during >6 months of LTOT
90 Randomization to NIV plus
LTOT vs. LTOT
2 years Survival and hospitalization similar, 
dyspnea and health-related quality of 
life better in NIV group
Casanova
et al. [46]
Patients with stable severe COPD 52 Randomization to NIV plus
standard care vs. standard care
1 year Survival and exacerbations similar, 
dyspnea better in NIV group
NIV = Noninvasive ventilation; LTOT = long-term oxygen therapy.
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